Hiring?
Logo

Accanis Biotech

location_on

Austria

Short Summary

ACCANIS is developing novel, mRNA-based therapeutics for local skin diseases (non-melanoma skin cancer (NMSC including actinic keratosis, AK) and skin rejuvenation. Our mission is to pioneer mRNA-based blockbuster treatments for the skin.

Overview

Target
A$9,000,000
Minimum
A$1,000,000
Investment Raised
N/A
Previous Rounds A$8,000,000
Stage Other
Investor Role Any

Highlights

  • mRNA-based therapy for actinic keratosis (high relevance in Australia!)
  • Lead product candidates /compounds identified and patent protected
  • High medical need and huge markets
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
0% raised

iScope

location_on Queensland, Australia

The iScope is a digital medical device that enables general practitioners to examine patients’ ears, eyes and skin, while supporting wireless recording of digital images, and performing billable procedures that require a referral to a specialist.

A$ 500,000

Target

A$ 5,000

Min per Investor

Global Pro
75% raised

The Future of Cannabis

location_on Victoria, Australia

Montu is providing patients with access to life-changing cannabis medication through a growing nationwide network of doctors. Changing cannabis legislation has opened a new chapter in healthcare with access to safer and healthier medication.

A$ 2,000,000

Target

A$ 1,000

Min per Investor

Global Pro
0% raised

We have the solution

location_on Queensland, Australia

It is estimated that around 45% of men and 35% of women snore. Snoring has been medically proven to contribute to major health problems and is associated with disrupted sleep and an increased risk for Sleep Apnea. Zip Snore may be the solution

A$ 350,000

Target

A$ 15,000

Min per Investor

load one similar proposal